Skip to content

Ast-ST01

by Autobio Diagnostics Co., Ltd.

Ref ME1201, ME1203, ME1202Model Automated Microbiology System Analyzer

Ast-ST01 (ME1201) is an in vitro diagnostic device (EU IVDR Class C; EMDN category gram positive susceptibility testing - automated) made by Autobio Diagnostics Co., Ltd., registered in EUDAMED on 19 Dec 2025 (Basic UDI-DI 697015090000195HS), active as of 22 Oct 2026.

Active European Union

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number697015090000195HS Basic UDI-DI Date19 Dec 2025RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Model / reference
Automated Microbiology System Analyzer, ME1201, ME1203, ME1202
Primary DI / UDI-DI
06942359535403, 06942359535427, 06942359535410
Basic UDI-DI
697015090000195HS
EMDN code
W0104080108 Gram positive susceptibility testing - automated
Device class
Class C
EU registration type
Standard device
EU market of registration
Italy

Manufacturer details

EUDAMED SRN
CN-MF-000003348
Authorised representative
QbD RepS BV BE-AR-000000040

Similar devices in this category

Other devices filed under GRAM POSITIVE SUSCEPTIBILITY TESTING - AUTOMATED.

Other devices from Autobio Diagnostics Co., Ltd.

See all devices from Autobio Diagnostics Co., Ltd. →

Properties

  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
Other properties (8, all answered No)